346 articles published
Schell died of natural causes in the early morning hours at UCLA Hospital on Friday.
Three key drugs, including Revlimid and Eliquis, are losing patent protection over the next couple of years, putting pressure on revenue.
The data analytics company posted its highest-ever year-over-year revenue growth rate of 85% in its latest quarter, reaching more than $1.6 billion.
Wood's flagship Ark Innovation ETF is down 2.85% this year while the S&P 500 has gained 8.56%.
The UN agency said the terminations were taken to reduce security risks, not as confirmation of the accusations against the workers.
Pakistan's prime minister said on Saturday that electronic signing of the agreement could happen within 24 hours.
The rocket company debuted on Nasdaq at a $2 trillion valuation, instantly making Elon Musk the world's first trillionaire.
California's attorney general is still investigating the deal, and European regulators have set a July 14 deadline to complete their review.
CNBC's Jim Cramer called the stock a long-term bet on space exploration, not a short or medium-term investment.
West Texas Intermediate and Brent crude both fell Friday on reports that a potential agreement could lift oil sanctions on Iran and reopen the Strait of Hormuz.
More than 1,400 professors signed an open letter warning that incoming students are arriving without basic math skills, prompting a formal policy review by the UC Board of Regents.
The offering places SpaceX at a $1.77 trillion valuation, which would make it the seventh-largest U.S. company by market cap on day one.
We use cookies to improve your experience and serve relevant ads. See our Privacy Policy for details.
